Author:
Sim Ruth,Chong Chun Wie,Loganadan Navin Kumar,Saidoung Pantakarn,Adam Noor Lita,Hussein Zanariah,Chaiyakunapruk Nathorn,Lee Shaun Wen Huey
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference58 articles.
1. What are the direct medical costs of managing type 2 diabetes mellitus in Malaysia?;Feisul;Med J Malays,2017
2. Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults;Raghavan;J Am Heart Assoc,2019
3. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes;Gæde;N Engl J Med,2003
4. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2020;Diabetes Care,2020
5. 2019 Update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Buse;Diabetes Care,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献